Invitae Corp at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 11, 2021 / 06:00PM GMT
Daniel Gregory Brennan - UBS Investment Bank, Research Division - Former Senior Equity Research Analyst of Healthcare Life Sciences

So we're going to get started here on the next panel. (Operator Instructions). But excited to be hosting Sean George, CEO of Invitae. Hi, Sean, welcome.

Sean Emerson George - Invitae Corporation - Co-Founder, President, CEO & Director

Thanks. Thanks for having me.

Questions and Answers:

Daniel Gregory Brennan - UBS Investment Bank, Research Division - Former Senior Equity Research Analyst of Healthcare Life Sciences

Great. So maybe just to get started, the company recently reported 2Q where you said it was going to be at the high end of its previous 50% to 60% revenue growth range. Can you talk a little bit on what trends you're seeing that give you confidence in that level of growth?

Sean Emerson George - Invitae Corporation - Co-Founder, President, CEO & Director

Yes. I think we look at -- I mean, well, first, it's just daily
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot